Client Perspectives on the Accessibility and Quality of Substance Use Treatment During the COVID-19 Pandemic

Overview

Journal Drug Alcohol Depend Rep

Specialty Psychiatry

Date 2022 Feb 14

PMID 35156104

Authors

Randolph D Hubach

Andrew M ONeil

Campbell Ernst

Mollie Stowe

Mark Hickey

Molly Remondino

Zachary Giano

Affiliations

Soon will be listed here.

Abstract

Background: People who use drugs have been particularly vulnerable during the COVID-19 pandemic because of their unique social, harm reduction, and treatment needs. These unique needs and challenges have significant influence on the severity of their substance use, mental health symptomatology, willingness to engage in treatment, and adherence to treatment options. This has included immense challenges related to the dissemination of COVID-19 messaging and the need for harm reduction and treatment service entities to adopt new formats to continue operation.

Methods: In-depth interview data were collected people who use drugs (=24) residing in Oklahoma from November 2020 through February 2021 to assess perspectives on (1) their access to harm reduction, substance use prevention, and treatment programs during the COVID-19 pandemic, (2) the perceived quality of such services and programs during this time, and (3) the perceived availability of tailored COVID-19 information.

Results: Several factors emerged related to accessing and quality of substance use services during COVID-19, including poor accessibility (e.g., internet access), diminished quality (i.e., lack of social support), and lack of tailored COVID-19 prevention and treatment messaging.

Conclusions: Upticks in COVID-19 cases and deaths are expected to continue as new SARS-CoV-2 variants are introduced. The present findings highlight the need for tailored COVID-19 messaging (e.g., minimizing the sharing of substance use supplies that can spread COVID-19, mask wearing, COVID-19 vaccination), which is responsive to unique needs of substance using populations. Similarly, as prevention and treatment programs are delivered online, efforts are necessary to ensure equitable access and enhanced quality of services.

Citing Articles

Methamphetamine use and adoption of preventive behaviors early in the COVID-19 pandemic among men who have sex with men in Los Angeles, California.

Cohen J, Li M, Javanbakht M, Gorbach P, Shoptaw S Drug Alcohol Depend Rep. 2022; 5:100097.

PMID: 36193108 PMC: 9519521. DOI: 10.1016/j.dadr.2022.100097.

References

McKetta S, Morrison C, Keyes K . Trends in US Alcohol Consumption Frequency During the First Wave of the SARS-CoV-2 Pandemic. Alcohol Clin Exp Res. 2021; 45(4):773-783. PMC: 8014717. DOI: 10.1111/acer.14575. View

McDonnell A, MacNeill C, Chapman B, Gilbertson N, Reinhardt M, Carreiro S . Leveraging digital tools to support recovery from substance use disorder during the COVID-19 pandemic response. J Subst Abuse Treat. 2020; 124:108226. PMC: 8005450. DOI: 10.1016/j.jsat.2020.108226. View

Hansen M, Modak S, McMaster S, Zoorob R, Gonzalez S . Implementing peer recovery coaching and improving outcomes for substance use disorders in underserved communities. J Ethn Subst Abuse. 2020; 21(3):1029-1042. DOI: 10.1080/15332640.2020.1824839. View

Litt D, Rodriguez L, Stewart S . Examining Associations Between Social Networking Site Alcohol-Specific Social Norms, Posting Behavior, and Drinking to Cope During the COVID-19 Pandemic. Cyberpsychol Behav Soc Netw. 2021; 24(11):715-721. DOI: 10.1089/cyber.2020.0568. View

Saltzman L, Hansel T, Bordnick P . Loneliness, isolation, and social support factors in post-COVID-19 mental health. Psychol Trauma. 2020; 12(S1):S55-S57. DOI: 10.1037/tra0000703. View

Kelly J . Popular opinion leaders and HIV prevention peer education: resolving discrepant findings, and implications for the development of effective community programmes. AIDS Care. 2003; 16(2):139-50. DOI: 10.1080/09540120410001640986. View

Jemberie W, Stewart Williams J, Eriksson M, Gronlund A, Ng N, Blom Nilsson M . Substance Use Disorders and COVID-19: Multi-Faceted Problems Which Require Multi-Pronged Solutions. Front Psychiatry. 2020; 11:714. PMC: 7396653. DOI: 10.3389/fpsyt.2020.00714. View

Wardell J, Kempe T, Rapinda K, Single A, Bilevicius E, Frohlich J . Drinking to Cope During COVID-19 Pandemic: The Role of External and Internal Factors in Coping Motive Pathways to Alcohol Use, Solitary Drinking, and Alcohol Problems. Alcohol Clin Exp Res. 2020; 44(10):2073-2083. DOI: 10.1111/acer.14425. View

Luchetti M, Lee J, Aschwanden D, Sesker A, Strickhouser J, Terracciano A . The trajectory of loneliness in response to COVID-19. Am Psychol. 2020; 75(7):897-908. PMC: 7890217. DOI: 10.1037/amp0000690. View

10.

Spagnolo P, Montemitro C, Leggio L . New Challenges in Addiction Medicine: COVID-19 Infection in Patients With Alcohol and Substance Use Disorders-The Perfect Storm. Am J Psychiatry. 2020; 177(9):805-807. PMC: 9366241. DOI: 10.1176/appi.ajp.2020.20040417. View

11.

Bergman B, Kelly J, Fava M, Evins A . Online recovery support meetings can help mitigate the public health consequences of COVID-19 for individuals with substance use disorder. Addict Behav. 2020; 113:106661. PMC: 7493730. DOI: 10.1016/j.addbeh.2020.106661. View

12.

Kleinman M, Felton J, Johnson A, Magidson J . "I have to be around people that are doing what I'm doing": The importance of expanding the peer recovery coach role in treatment of opioid use disorder in the face of COVID-19 health disparities. J Subst Abuse Treat. 2020; 122:108182. PMC: 7577312. DOI: 10.1016/j.jsat.2020.108182. View

13.

Rozanova J, Shenoi S, Zaviryukha I, Zeziulin O, Kiriazova T, Rich K . Social Support is Key to Retention in Care during Covid-19 Pandemic among Older People with HIV and Substance Use Disorders in Ukraine. Subst Use Misuse. 2020; 55(11):1902-1904. PMC: 7523433. DOI: 10.1080/10826084.2020.1791183. View

14.

Mericle A, Sheridan D, Howell J, Braucht G, Karriker-Jaffe K, Polcin D . Sheltering in place and social distancing when the services provided are housing and social support: The COVID-19 health crisis and recovery housing. J Subst Abuse Treat. 2020; 119:108094. PMC: 7395628. DOI: 10.1016/j.jsat.2020.108094. View

15.

Lin C, Clingan S, Cousins S, Valdez J, Mooney L, Hser Y . The impact of COVID-19 on substance use disorder treatment in California: Service providers' perspectives. J Subst Abuse Treat. 2021; 133:108544. PMC: 8702565. DOI: 10.1016/j.jsat.2021.108544. View

16.

Wang L, Weiss J, Ryan E, Waldman J, Rubin S, Griffin J . Telemedicine increases access to buprenorphine initiation during the COVID-19 pandemic. J Subst Abuse Treat. 2021; 124:108272. PMC: 7833481. DOI: 10.1016/j.jsat.2020.108272. View

17.

Mota P . Avoiding a new epidemic during a pandemic: The importance of assessing the risk of substance use disorders in the COVID-19 era. Psychiatry Res. 2020; 290:113142. PMC: 7253943. DOI: 10.1016/j.psychres.2020.113142. View

18.

Caton L, Cheng H, Garneau H, Fisher T, Harris-Mills B, Hurley B . COVID-19 Adaptations in the Care of Patients with Opioid Use Disorder: a Survey of California Primary Care Clinics. J Gen Intern Med. 2021; 36(4):998-1005. PMC: 7842998. DOI: 10.1007/s11606-020-06436-3. View

19.

Pagano A, Hosakote S, Kapiteni K, Straus E, Wong J, Guydish J . Impacts of COVID-19 on residential treatment programs for substance use disorder. J Subst Abuse Treat. 2020; 123:108255. PMC: 7953585. DOI: 10.1016/j.jsat.2020.108255. View

20.

Graupensperger S, Fleming C, Jaffe A, Rhew I, Patrick M, Lee C . Changes in Young Adults' Alcohol and Marijuana Use, Norms, and Motives From Before to During the COVID-19 Pandemic. J Adolesc Health. 2021; 68(4):658-665. PMC: 8345007. DOI: 10.1016/j.jadohealth.2021.01.008. View